| DAIICHI SANKYO CO. LTD |
| Japan |
| Gesundheit |
| JP3475350009 / A0F57T |
| D4S (Frankfurt) |
| FRA:D4S, ETR:D4S, D4S:GR |
| Nikkei225 |
| https://www.daiichisankyo.. |
|
Daiichi Sankyo Co., Ltd. is a Japan-based pharmaceutical company specializing in the research, development, and commercialization of innovative medicines. Formed in 2005 through the merger of Daiichi Pharmaceutical and Sankyo, the company focuses pri..
>Volltext.. |
| 25042.38 Mio. EUR |
| 24499.25 Mio. EUR |
| 11745.38 Mio. EUR |
| 1663.97 Mio. EUR |
| 1437.71 Mio. EUR |
| 0.78 EUR |
| 1936.6 Mio. EUR |
| 1469.96 Mio. EUR |
| 429.61 Mio. EUR |
| 0.51 |
| -0.43% |
| -22.27% |
| 0.44 EUR |
| 3.04% |
| 4% |
| 30.03.26 - 0.21295445€ 29.09.25 - 0.2222064€ >weitere anzeigen... |
| - |
| DAIICHI SANKYO |
| 29.06.26 |
|
||||
|